HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Daniel E Furst Selected Research

CT-P17

11/2022Efficacy and safety of switching from reference adalimumab to CT-P17 (100 mg/ml): 52-week randomized, double-blind study in rheumatoid arthritis.
1/2021Efficacy and safety of biosimilar CT-P17 versus reference adalimumab in subjects with rheumatoid arthritis: 24-week results from a randomized study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Daniel E Furst Research Topics

Disease

99Rheumatoid Arthritis
11/2022 - 03/2002
68Systemic Scleroderma (Systemic Sclerosis)
05/2022 - 05/2002
32Interstitial Lung Diseases (Interstitial Lung Disease)
01/2022 - 02/2005
18Infections
12/2020 - 10/2004
17Fibrosis (Cirrhosis)
05/2022 - 05/2006
16Diffuse Scleroderma (Progressive Systemic Sclerosis)
07/2021 - 11/2002
13Dyspnea (Shortness of Breath)
04/2017 - 02/2005
11Inflammation (Inflammations)
05/2022 - 07/2011
10Autoimmune Diseases (Autoimmune Disease)
02/2021 - 05/2002
10Rheumatic Diseases (Rheumatism)
12/2019 - 05/2003
10Pulmonary Arterial Hypertension
09/2017 - 09/2006
9Pain (Aches)
04/2022 - 03/2002
9Arthritis (Polyarthritis)
01/2017 - 05/2002
7Heart Failure
01/2017 - 01/2004
6Fatigue
04/2022 - 07/2011
6Juvenile Arthritis (Juvenile Idiopathic Arthritis)
06/2018 - 05/2002
6Psoriatic Arthritis
06/2017 - 04/2005
5Neoplasms (Cancer)
01/2021 - 01/2008
5Lung Diseases (Lung Disease)
06/2020 - 06/2006
5digital ulcers
02/2019 - 09/2002
5Necrosis
10/2018 - 01/2004
5Tuberculosis (Tuberculoses)
01/2016 - 07/2009
4Osteoarthritis
04/2022 - 12/2005
4Chronic Disease (Chronic Diseases)
04/2022 - 07/2011
4Connective Tissue Diseases (Connective Tissue Disease)
01/2021 - 12/2013
4Pulmonary Hypertension
09/2017 - 05/2003
4Systemic Lupus Erythematosus (Libman-Sacks Disease)
07/2014 - 05/2002
3Skin Ulcer
01/2021 - 05/2016
3Leukopenia
05/2020 - 12/2004
3Ulcer
06/2018 - 01/2011
3Skin Diseases (Skin Disease)
06/2017 - 05/2008
3Psoriasis (Pustulosis Palmaris et Plantaris)
06/2017 - 04/2005
3Hypertension (High Blood Pressure)
01/2017 - 03/2007
3Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
08/2015 - 08/2006
3Gout
08/2011 - 08/2006
3Knee Osteoarthritis
08/2010 - 02/2006
3Pancytopenia
12/2009 - 01/2004
3Multiple Sclerosis
10/2006 - 09/2003
3Graft vs Host Disease (Graft-Versus-Host Disease)
06/2006 - 10/2002
2Vomiting
09/2022 - 04/2010
2Anemia
04/2022 - 05/2016
2Sclerosis
01/2022 - 04/2009
2Disease Progression
08/2020 - 01/2008
2Edema (Dropsy)
01/2018 - 05/2016

Drug/Important Bio-Agent (IBA)

27Methotrexate (Mexate)FDA LinkGeneric
01/2019 - 08/2002
25Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2021 - 05/2003
23Biological ProductsIBA
05/2022 - 01/2004
22Antirheumatic Agents (DMARD)IBA
04/2022 - 05/2003
16Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2019 - 01/2003
14ametantrone (HAQ)IBA
04/2022 - 09/2002
11Biomarkers (Surrogate Marker)IBA
05/2022 - 09/2006
11Abatacept (Orencia)FDA Link
12/2020 - 03/2010
9Adalimumab (Humira)FDA Link
11/2022 - 01/2003
9tocilizumab (atlizumab)FDA Link
01/2022 - 03/2010
9Pharmaceutical PreparationsIBA
12/2019 - 01/2004
9Tumor Necrosis Factor InhibitorsIBA
08/2015 - 10/2004
7Rituximab (Mabthera)FDA Link
03/2020 - 12/2007
7Infliximab (Remicade)FDA Link
11/2016 - 04/2005
6Monoclonal AntibodiesIBA
05/2022 - 01/2003
6CytokinesIBA
05/2022 - 06/2003
6Proteins (Proteins, Gene)FDA Link
01/2021 - 10/2003
5Carbon MonoxideIBA
04/2017 - 02/2005
4Adrenocorticotropic Hormone (ACTH)FDA Link
04/2022 - 06/2020
4Immunosuppressive Agents (Immunosuppressants)IBA
01/2021 - 03/2016
4Mycophenolic Acid (Cellcept)FDA LinkGeneric
06/2020 - 01/2016
4Certolizumab PegolFDA Link
10/2017 - 03/2009
4CreatinineIBA
01/2017 - 11/2008
4Immunoglobulins (Immunoglobulin)IBA
10/2015 - 05/2003
4Immunoglobulin G (IgG)IBA
09/2013 - 10/2003
4Bosentan (Tracleer)FDA Link
01/2011 - 05/2003
4Etanercept (Enbrel)FDA Link
09/2010 - 07/2007
3tofacitinibIBA
04/2022 - 01/2016
3AntibodiesIBA
06/2021 - 12/2004
3AntigensIBA
01/2021 - 05/2019
3Interleukin-6 (Interleukin 6)IBA
10/2020 - 04/2014
3Adrenal Cortex Hormones (Corticosteroids)IBA
06/2020 - 06/2006
3Interleukin-17 (Interleukin 17)IBA
01/2019 - 09/2014
3Imatinib Mesylate (Gleevec)FDA Link
01/2018 - 11/2011
3Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
04/2014 - 09/2006
3golimumabFDA Link
10/2013 - 03/2010
3Folic Acid (Vitamin M)FDA LinkGeneric
09/2013 - 10/2005
3Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
11/2012 - 12/2005
3ColchicineFDA LinkGeneric
08/2011 - 04/2010
3Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link
07/2011 - 12/2004
3EnzymesIBA
09/2010 - 02/2006
3Glucosamine (Dona)IBA
08/2010 - 02/2006
3ChondroitinIBA
08/2010 - 02/2006
3Leflunomide (Arava)FDA LinkGeneric
10/2005 - 11/2002
2CT-P17IBA
11/2022 - 01/2021
2C-Reactive ProteinIBA
04/2022 - 11/2012
2lenabasum (ajulemic acid)IBA
07/2021 - 01/2020
2Blood Proteins (Serum Proteins)IBA
01/2021 - 04/2014
2InterferonsIBA
01/2021 - 09/2006
2Intravenous Immunoglobulins (IVIG)FDA Link
05/2019 - 05/2003
2SteroidsIBA
10/2018 - 07/2011

Therapy/Procedure

54Therapeutics
04/2022 - 11/2002
6Stem Cell Transplantation
02/2021 - 05/2002
5Cell Transplantation
01/2022 - 12/2004
5Hematopoietic Stem Cell Transplantation
02/2021 - 09/2003
4Transplantation
10/2019 - 05/2005